Teplizumab drug to delay type 1 diabetes to be rolled out on the NHS
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Teplizumab drug to delay type 1 diabetes to be rolled out on the NHS" is generating significant coverage in the Health category, with 5 articles from 5 distinct sources tracked by PULSE so far.
Outlets currently covering the story include The Sun, Diabetes UK, Citeline News & Insights and The Times. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 45d ago.
Quick answers
Why is "Teplizumab drug to delay type 1 diabetes to be rolled out on the NHS" trending?
Because 5 independent news sources published 5 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (7)
- Drug that delays type 1 diabetes approved for NHS The Telegraph · 45d ago
- Drug that delays onset of type 1 diabetes approved in England and Wales The Guardian · 45d ago
- Breakthrough in type 1 diabetes as drug offered on NHS delays start of disease The Sun · 45d ago
- Teplizumab, the first treatment to slow type 1 diabetes, approved for use on the NHS Diabetes UK · 45d ago
- England Leads Europe In Reimbursing Sanofi’s Type 1 Diabetes Disease-Modifying Therapy Tzield Citeline News & Insights · 45d ago
- Type 1 diabetes drug will delay onset by three years The Times · 45d ago
- Teplizumab drug to delay type 1 diabetes to be rolled out on the NHS BBC · 45d ago
Topics
Related trends
Breast cancer checks missing most women under 50 who are at risk, says study
A Cambridge study warns that current NHS and NICE referral rules miss up to 95% of women under 50 at higher risk of developing breast cancer.
Donated lungs will be kept alive for up to six hours before transplant
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Multiple sclerosis: First drug to help patients walk now on NHS in England
Thousands of multiple sclerosis patients in England can now access the first drug approved to help improve walking.
How a Dermatologist Monitors Herself for Skin Cancer and the ‘Big Sign’ a Mole May Be Melanoma
Medical professionals and health authorities are urging the public to use specific checklists to identify potential melanoma and skin cancer signs this summer.
Rapid endometriosis tests to be made available on NHS in England and Wales
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Two tests GPs can soon offer to help spot endometriosis
NICE has recommended two non-invasive diagnostic tests for endometriosis that GPs will soon be able to offer patients.